These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37052031)

  • 1. Is Metformin effective in Breast Cancer (BC) patients without Type 2 Diabetes (T2D)?
    Siddiqui T; ; Doultani PR
    J Pak Med Assoc; 2023 Apr; 73(4):953. PubMed ID: 37052031
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: "Old warrior for a new battle".
    Jain A
    Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
    [No Abstract]   [Full Text] [Related]  

  • 5. New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis.
    Xu JX; Zhu QL; Bi YM; Peng YC
    BMC Cancer; 2024 Jun; 24(1):691. PubMed ID: 38844880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
    Hui T; Shang C; Yang L; Wang M; Li R; Song Z
    Sci Rep; 2021 May; 11(1):10034. PubMed ID: 33976288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term metformin use is associated with decreased risk of breast cancer.
    Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
    Diabetes Care; 2010 Jun; 33(6):1304-8. PubMed ID: 20299480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
    Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes.
    Jacob L; Kostev K; Rathmann W; Kalder M
    J Diabetes Complications; 2016 Aug; 30(6):1056-9. PubMed ID: 27130560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
    Barba M; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and breast cancer: an opportunity for pharmacogenetics.
    Cuyàs E; Martin-Castillo B; Menendez JA
    Aging (Albany NY); 2022 Jul; 14(14):5612-5613. PubMed ID: 35852878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].
    Bershteĭn LM; Turkevich EA; Boiarkina MP
    Vopr Onkol; 2012; 58(2):194-8. PubMed ID: 22774523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metformin can reduce the risk of colorectal cancer].
    Fransgård T; Gögenur I
    Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.